Two genes (CD99, CD135) were upregulated in each AML subgroup compared to healthy/normal samples, and five genes (CD24, CD66b, CD66c, CD218b, CD233) were expressed significantly lower. The gene discussed is CEACAM6; the disease is acute myeloid leukemia.